Spencer Claudio poj jose JAHA paper.pdf (1.43 MB)
The histone deacetylase inhibitor JAHA down-regulates pERK and global DNA methylation in MDA-MB231 breast cancer cells
journal contribution
posted on 2023-06-08, 22:52 authored by Mariangela Librizzi, Roberto Chiarelli, Liana Bosco, Supojjanee Sansook, Jose M Gascon, John SpencerJohn Spencer, Fabio Caradonna, Claudio LuparelloThe histone deacetylase inhibitor N1-(ferrocenyl)-N8-hydroxyoctanediamide (JAHA) down-regulates extracellular-signal-regulated kinase (ERK) and its activated form in triple-negative MDA-MB231 breast cancer cells after 18 h and up to 30 h of treatment, and to a lesser extent AKT and phospho-AKT after 30 h and up to 48 h of treatment. Also, DNA methyltransferase 1 (DNMT1), 3b and, to a lesser extent, 3a, downstream ERK targets, were down-regulated already at 18 h with an increase up to 48 h of exposure. Methylation-sensitive restriction arbitrarily-primed (MeSAP) polymerase chain reaction (PCR) analysis confirmed the ability of JAHA to induce genome-wide DNA hypomethylation at 48 h of exposure. Collective data suggest that JAHA, by down-regulating phospho-ERK, impairs DNMT1 and 3b expression and ultimately DNA methylation extent, which may be related to its cytotoxic effect on this cancer cytotype.
History
Publication status
- Published
File Version
- Published version
Journal
MaterialsISSN
1996-1944Publisher
MDPIExternal DOI
Issue
10Volume
8Page range
7041-7047Department affiliated with
- Chemistry Publications
Full text available
- Yes
Peer reviewed?
- Yes
Legacy Posted Date
2015-10-22First Open Access (FOA) Date
2015-10-22First Compliant Deposit (FCD) Date
2015-10-20Usage metrics
Categories
No categories selectedKeywords
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC